CVR number 35867732
Industry 869400

SIGNES JORDEMODER- OG SCANNINGSKLINIK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.6% 9.7% 5.8% 5.6% 5.0%  
Credit score (0-100)  21 24 39 40 44  
Credit rating  BB BB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  2,184 2,587 2,582 1,935 1,509  
EBITDA  93.6 502 401 265 522  
EBIT  66.1 438 323 190 447  
Pre-tax profit (PTP)  62.4 432.6 322.4 188.3 445.1  
Net earnings  47.0 335.9 256.4 161.4 345.1  
Pre-tax profit without non-rec. items  62.4 433 322 188 445  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  59.9 745 667 592 517  
Shareholders equity total  104 389 531 575 798  
Interest-bearing liabilities  0.0 0.0 5.0 4.7 7.4  
Balance sheet total (assets)  741 974 934 883 1,139  
Net Debt  -572 -46.7 -137 -168 -492  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,184 2,587 2,582 1,935 1,509  
Gross profit growth  10.9% 18.5% -0.2% -25.1% -22.0%  
Employees  4 4 3 3 1  
Employee growth %  33.3% 0.0% -25.0% 0.0% -66.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  741 974 934 883 1,139  
Balance sheet change%  21.0% 31.4% -4.1% -5.4% 29.0%  
Added value  93.6 502.5 401.3 267.9 522.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -55 620 -156 -150 -150  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  3.0% 16.9% 12.5% 9.8% 29.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.8% 51.0% 33.9% 20.9% 44.3%  
ROI %  49.7% 166.0% 64.3% 31.4% 60.5%  
ROE %  43.6% 136.2% 55.7% 29.2% 50.3%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  14.0% 40.0% 56.9% 65.1% 70.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -611.0% -9.3% -34.2% -63.5% -94.2%  
Gearing %  0.0% 0.0% 0.9% 0.8% 0.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 33.8% 34.3% 42.9%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.9 0.3 0.5 0.8 1.8  
Current Ratio  0.9 0.3 0.5 0.8 1.8  
Cash and cash equivalent  571.8 46.7 142.2 172.9 499.6  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -37.1 -407.6 -179.2 -63.5 239.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  23 126 134 89 522  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  23 126 134 88 522  
EBIT / employee  17 109 108 63 447  
Net earnings / employee  12 84 85 54 345